Archive for category: HIV/AIDS

, ,

The Progress of HIV/AIDS in Azerbaijan

HIV/AIDS in AzerbaijanHIV is a communicable disease that attacks the human immune system. It destroys CD4 cells, otherwise known as white blood cells. As time goes on, it weakens the immune system. As a result, it causes opportunistic infections such as fungal infections, tuberculosis and some cancers. Many patients do not feel symptoms of HIV for a few months after infection, and as a result, do not realize they have the disease. Compared to Europe, HIV/AIDS in Azerbaijan is comparatively low, but it is still a significant problem. The rate of new HIV infections increased by 0.09 per 1,000 uninfected people from 0.01 in 1990 to 0.1 in 2024.

Treatments for HIV/AIDS

Antiretroviral treatment (ART) prevents HIV transmission from mother to child through breastfeeding. Patients who use ART can also prevent HIV transmission to their sexual partners. However, patients must take ART every day for life. Moreover, reducing HIV transmission connects to harm reduction approaches, which specifically involves the provision of sterile injecting equipment. It proves that harm reduction services include not only needle and syringe programs but also the provision of opioid agonist treatment (OAT).

The Causes of HIV/AIDS in Azerbaijan

On August 3rd, 2016, there were 4,955 HIV-infected people in Azerbaijan; 73.2% of them were men while 26.8% were women. The most significant cause of HIV/AIDS in Azerbaijan was the use of drugs, accounting for 47% of cases. Meanwhile, the second-highest cause was heterosexual contact at 42.1% and the third-highest cause was unknown causes at 7.8%. Finally, the fourth-highest cause was homosexual acts at 1.8% and the fifth-highest cause was mother-to-child transmission, affecting 1.8%.

In Azerbaijan, HIV infection is a serious problem with many cases being connected to people who injected drugs. According to the official statistics of 2021, injection drug use caused 14% of new HIV infections in the country. Of 690 HIV infections, 97 people were people who injected drugs (PWID).

Treating HIV/AIDS in Azerbaijan

Of the 26,894 people in prison in Azerbaijan, 7,979 people were in prison because of illegal drugs on January 31st, 2023. In prison, HIV prevalence was 1.7% in 2020. ART has been available in prisons resulting in 91.8% prisoners receiving treatment in 2019. However, NSP and opioid substitution therapy (OST) were not accessible.

Access to treatment can be challenging for people in Azerbaijan. For example, the needle/syringe program (NSP) covered only 33.9% for each client, providing 55 needles and the unit cost was approximately €33. Meanwhile, OAT coverage was about 1% in 2024 and the price of it was about €133 per client in a year. However, the unemployment benefit proxy was just €1,245. In prison, imprisonment costs about €3,008 per person per year. A simple community package including NSP and OAT and the unemployment benefit were about €1,411 per person per year.

Women’s Challenges and Barriers to Health Care

According to a Eurasian Women’s Network on AIDS study in 2022, Azerbaijan’s National HIV Program did not particularly support women. The overall plan did not include information on addressing stigma, discrimination and human rights for women experiencing HIV, working as sex workers or using drugs.

Additionally, as the Republican AIDS Center mentioned in May 2025, 10,324 respondents living with HIV/AIDS in Azerbaijan mentioned that they faced stigma and barriers to accessing health care and testing services. According to HIV/AIDS patients, access to stigma-free, confidential testing and treatment services need to be a priority for Azerbaijan’s public health strategy in addition to addressing discrimination.

Progress Addressing HIV/AIDS in Azerbaijan

For the voluntary licensing agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare in late 2020, Azerbaijan was able to access dolutegravir (DTG) based on the regimens in upper-middle-income countries, which included Azerbaijan, Belarus and Kazakhstan. In addition, ViiV Healthcare and MPP developed the first-of-its-kind agreement to increase access and affordability to DTG-based HIV treatment plans. As a result, Azerbaijan was able to reduce the price by more than 90% through efforts of communities, procurement agencies and others. The government of Azerbaijan began the actions concerning the import of specific syringes to prevent HIV/AIDS in Azerbaijan.

In 2025, the Ministry of Health mentioned that it will allocate $431,000 for the procurement of these specific syringes. As a component of the “Harm Reduction” project, the government will buy the syringes with a “low dead space.” They expect that these syringes will help prevent HIV.

The Azerbaijan Parliament adopted a new law on HIV/AIDS. It concentrated on human rights and the universal accessibility of HIV-related services, including services targeted at drug users who are both in and out of prison. With the support of United Nations Office on Drugs and Crime (UNODC) and national experts, it could develop these recommendations.

As mentioned by Ali Hassanov, Deputy Prime Minister of the Republic of Azerbaijan, National legislation and policy had to consider the interests and needs of people who injected drugs and prisoners. He also mentioned that efforts to address the social and economic risk factors for HIV infection were an important part of an efficient strategy to reducing the spread of HIV in the years to come. The social and economic factors meant that they deprived individuals of the power to protect themselves against HIV infection.

In addition, Hadi Rajabli, Chair of the Social Policy Committee mentioned that the new law included the prohibition of discrimination and stigmatization. It contained programs to prevent the contraction of HIV among at-risk groups and prison inmates.

Looking Ahead

The issue of HIV/AIDS in Azerbaijan is still challenging. However, Azerbaijan’s efforts have helped reduce the price of treatments by 90% and it expects that HIV prevention plans will improve. Furthermore, the parliament accepted a new law on HIV/AIDS with the aid of UNODC and national experts.

– Yunjae Lee

Yunjae is based in Vancouver, Canada and focuses on Global Health and Politics for The Borgen Project.

Photo: Unsplash

, ,

Addressing Syphilis, Hepatitis B and HIV/AIDS in the Maldives

HIV/AIDS in MaldivesIn October 2025, the World Health Organization (WHO) officially declared that the Maldives had become the first country in the world to accomplish ‘triple elimination’ of mother-to-child transmission of HIV, syphilis and hepatitis B. As a nation, the Maldives has demonstrated a dedication to targeted, all-encompassing health care, providing a blueprint for the rest of the world to follow in its footsteps towards a collective aim of eliminating preventable disease transmission. This milestone holds the promise of a protected generation born free of infection, making it more than just a medical triumph. The reduction of HIV/AIDS in the Maldives serves as a reminder worldwide that even smaller nations can spearhead global change with the right commitment and focus.

The Meaning of Triple Elimination

Essentially, in global health terms, “triple elimination” marks one of the highest standards a country can achieve: a victory against three life-threatening diseases. It represents an implication that mothers are no longer infecting their offspring with hepatitis B, syphilis or HIV, three diseases that took the lives of countless newborns. Although the diseases have not completely perished, their transmission has dropped to the point that they are no longer a concern to public health. Although these infections still exist, transmission rates fall below strict WHO thresholds. To receive recognition, a country must:

  • Test and treat nearly all pregnant women
  • Provide prompt newborn interventions, including the hepatitis B birth dose within 24 hours
  • Maintain consistent outcomes over several years

Triple elimination fundamentally demonstrates what can be achieved when governmental, medical and scientific efforts come together to provide every baby with an optimal start in life.

Mother-To-Child Transmission on the World Stage

Globally, an estimated 1.3 million women and girls living with HIV become pregnant each year. Congenital syphilis is the second leading cause of preventable stillbirth globally, preceded only by malaria. Hepatitis B, on the other hand, is a liver-attacking virus that can infect a newborn and cause chronic illness in later life. However, early detection, treatment and prompt vaccination—especially the hepatitis B birth dose within 24 hours of delivery—can prevent these diseases.

According to UNICEF, new HIV infections among children under five dropped by 62% between 2010 and 2024. However, to meet the 2030 goals that UNAIDS and its partners established as part of the UNAIDS Global Strategy to End AIDS, progress needs to be made at a much faster rate. To eradicate new infections in children and cut the number of HIV-related deaths among expectant mothers in half, treatment for all pregnant and nursing women living with HIV must be accelerated.

Where Poverty Fits In

Poverty increases vulnerability to mother-to-child transmission because families with low income often face:

  • Limited access to antenatal care
  • Delayed or missed screening
  • Higher rates of untreated infection
  • Less access to protection during intercourse
  • Difficulty affording transport or follow-up appointments

The Elimination of Mother-To-Child Transmission (EMTCT) Initiative

To assist nations in achieving these objectives, the World Health Organization (WHO) developed the Elimination of Mother-to-Child Transmission (EMTCT) initiative. Numerous countries have made strides with some succeeding in ‘dual elimination’ status for syphilis and HIV. However, no nation had ever successfully eliminated all three at the same time until the HIV/AIDS in the Maldives confirmation this year.

This makes EMTCT efforts essential for reducing inequality across countries, especially in regions with limited health care infrastructure. The Maldives became an active participant in the WHO South-East Asia Regional EMTCT Initiative in 2016. In 2018, due to the regulation provided by the EMTCT initiative, they implemented the ‘Agenda for Integrated Service Delivery’ and started a systematic data collection for HIV, syphilis and hepatitis B. The progress seen with HIV/AIDS in the Maldives highlights how strong public health systems can help overcome poverty-related barriers. 

In the Maldives, poverty and geographic isolation have historically increased the risk of mother-to-child transmission of infections like HIV, syphilis and hepatitis B. Dr Catharina Boehme, Officer-in-Charge at the WHO South-East Asia Regional Office, affirmed the significance of “equitable care across its dispersed islands.” The nation’s numerous outer islands have historically had lower income levels, fewer job prospects, and less access to social services than the capital region. Families in these islands were more likely to miss early screening or timely newborn vaccination due to reduced household income and inadequate health infrastructure, underscoring the connection between health risk and economic disadvantage. Acknowledging these disparities, the government structured its maternal health system on universal access: all islands now offer free testing, treatment and birth-dose vaccination, and the WHO’s EMTCT framework supports this model.

Maldive’s Methods

  1. Early and Universal Screening: By the mid-2010s, the Maldives integrated first-trimester HIV, syphilis and hepatitis B screening into routine antenatal care, ensuring that even women in remote islands received early diagnosis.
  2. High Antenatal Care Coverage: The government invested heavily in island-level health posts and trained midwives, increasing antenatal care coverage and reducing disparities between wealthier households and families experiencing poverty.
  3. Strong Vaccination Systems: The Maldives maintained hepatitis B birth-dose coverage above 95%, a key requirement for EMTCT validation. Skilled birth attendants on smaller islands received training to guarantee newborn vaccination within 24 hours.
  4. Free Access to Treatment: All testing and treatment for HIV, syphilis and hepatitis B were free of charge, removing financial barriers that typically disproportionately affect low-income families.
  5. Data-Driven Monitoring: Through support from the EMTCT initiative, the Maldives strengthened its data systems, enabling accurate tracking of infections, treatment uptake and birth outcomes.

Looking Ahead

Proving itself a leading agent in maternal and antenatal care, “The Maldives’ triple elimination stands as a powerful example of how sustained investment in health systems, innovation and community-based care can change the trajectory of public health,” said Ms. Payden, WHO Representative to the Maldives. The HIV/AIDS in the Maldives’ progress began more than a decade ago, long before triple elimination was in sight. Because its population is dispersed across more than 1,000 islands, the government prioritized a decentralized, community-based health care system to ensure equal access regardless of income or geography. As stated in the WHO’s South-East Asia update, the Maldives’ feat is credited to long-term, systemic investments that have sustained high antenatal care coverage and integrated first-trimester screening for all three infections across scattered island communities. For the children of the Maldives, the future now begins infection-free.

– Prubleen Bhogal

Prubleen is based in London, UK and focuses on Good News and Politics for The Borgen Project.

Photo: Pexels

, ,

Everything To Know About HIV/AIDS in Bolivia

HIV/AIDS in BoliviaHIV/AIDS in Bolivia affects less than 1% of the population. The U.S. Agency for National Development reports that this puts the country at the lowest in HIV prevalence within Latin America and the Caribbean region. Officials reported the first diagnosis of HIV in 1985. Although HIV prevalence has remained low, it disproportionately affects marginalized populations. Two populations that are disproportionately affected are men who have sex with other men (MSM) and transgender women. Societal stigma and prejudice against these groups have resulted, necessitating a response that addresses these specific issues. According to UNAIDS, infection rates have steadily declined since 1993 and reached about 0.16 per 1,000 people as of 2024. Death rates have also steadily declined since 2011. As of 2024, the death rate is about 0.04 per 1,000 people.

Background on HIV/AIDS

According to the World Health Organization (WHO), HIV is a virus that targets the immune system by attacking white blood cells. Bodily fluids from an infected person can spread HIV. This can include blood, breast milk, semen and vaginal fluids. Antiretroviral therapy treats HIV. Without treatment, HIV can develop into AIDS.

The Response

The United Nations developed UNAIDS, the Joint Programme on HIV/AIDS, to lead the global effort to eradicate it. UNAIDS’ main focus is to advocate for affected communities, provide technical support, collect data on the illness and assist countries that are most affected. The joint program in Bolivia has carried out various efforts to address HIV through prevention, testing and treatment. Community-based programs, supported by the Joint Programme, have provided access to HIV prevention packages in 2023 to MSM and transgender women. Furthermore, the Triple X (Xpressa, eXplora and eXige) campaign has run a social media initiative aimed at increasing condom usage. It has reached 111,000 young people and resulted in a 12% increase in condom distribution within the public health system in one year. Additionally, the government has developed national guidelines for pre-exposure prophylaxis with support from the World Health Organization (WHO) following its adoption of the preventive drug regimen.

Impacts of People in Poverty With HIV

People who live with HIV/AIDS in Bolivia face conditions conducive to poverty, such as food insecurity and unstable livelihoods face major obstacles in managing their treatment, indicating a connection between economic struggle and HIV-related health outcomes, according to a study performed by Palar and a team. The Pan American Health Organization (PAHO) states that more than a third of Bolivia’s population lived below the national poverty line in 2021, indicating economic strain that reflects the hardships patients described in the study.

Palar’s team determined that time conflicts with their jobs prevented many participants from getting their doses, the stigma of HIV caused the loss of jobs and that many HIV patients struggled to balance their treatments with expectations from informal or unpredictable employment. The study observes that these conditions directly impact antiretroviral adherence, especially for those who lack a stable income or consistent access to food. The team also notes that a food-assistance pilot program has helped ease these pressures through improving patients’ nutritional stability. This has helped patients take their medication correctly.

Addressing Disparities and Prejudices

Fighting HIV/AIDS in Bolivia importantly involves addressing the disparities within the populations it affects and the prejudices surrounding the disease. Capacity-building training and catalytic funding have supported civil society organizations in Bolivia to strengthen the HIV response, address stigma and discrimination and protect human rights. As UNAIDS reported, the Bolivian Network of People Living with HIV and the Ministry of Health have introduced a pulsometer, a pilot stigma and discrimination self-assessment tool, to gather data on stigma and discrimination directed toward people living with HIV and key populations within the healthcare system. This aims to address barriers to accessing services.

In 2022, officials created an essential care standard for vulnerable communities and integrated it across 3,000 health facilities. As UNAIDS outlined, this protocol includes guidelines that prevent stigma, ensure adherence to care and diagnosis standards for HIV and promote condom use. In an effort to decriminalize HIV transmission, REDBOL and the community-centered organization Asociación Un Nuevo Camino have created a project to modify the 2008 HIV law. Advocates organized social dialogues to pressure Congress.

Looking Ahead

Although HIV is not an epidemic among the general population in Bolivia, it is prevalent within concentrated communities. The government and external organizations have made consistent efforts to address and treat this disease. HIV carries significant societal stigma and prejudice; as such, the response has acknowledged discrimination against marginalized groups. The response has addressed the disease itself and has also worked to undo prejudice and discrimination toward marginalized communities.

– Sasha Banaei

Sasha is based in San Diego, CA, USA and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

Behind The Numbers: The Story of HIV/AIDS in Niger

HIV/AIDS in NigerNiger has one of the lowest HIV rates in sub-Saharan Africa – but experts warn that low prevalence does not mean low risk. Behind the calm statistics lies a fragile health system, deep gender disparities and poverty that magnifies every infection.

According to the Joint United Nations Program on HIV/AIDS (UNAIDS), as of 2020, about 31,000 people in Niger live with HIV, with roughly 1,200 new infections each year. While Index Mundi cites adult prevalence remaining steady at just 0.2% as of the same period, only 68% of those infected were on antiretroviral therapy (ART), leaving nearly a third untreated. In a country where more than 40% of citizens live in extreme poverty, these gaps carry steep social and economic costs.

A Hidden Epidemic

Health officials warn that Niger’s low HIV rate masks deeper weaknesses in detection and prevention. In an interview with the University Research Co, a company focused on international development and health, Halima Mainassara, Chief of Party for the U.S. Department of Defense HIV/AIDS Prevention Program (DHAPP) in Niger, reinforced the urgency of the disease, “Every new HIV case detected is important – their contacts also need to be tested,” says Mainassara, “This ensures that all individuals who test positive will receive treatment and that the virus cannot spread further.”

Despite gains – such as the integration of HIV and tuberculosis care in 262 treatment centers – resource shortages, long travel distances and stigma over HIV/AIDS in Niger still limit testing and follow-up, according to the World Health Organization – Africa (WHO AFRO). Per the same report, mortality among TB/HIV co-infected patients fell from 21% in 2019 to 14% in 2022, but coverage remains uneven between cities and rural areas.

Gender and Youth at the Margins

Women and young girls carry most of the burden. UNAIDS data from 2021 shows they account for just under 55% of HIV cases in Niger, reflecting social inequalities that restrict education, health care access and decision-making. Early marriage, gender-based violence and limited reproductive services heighten vulnerability.

“When a woman is divorced as a result of her HIV status, it is difficult for her to keep her children,” said Sona Soumaré Conté, President of an NGO working with HIV-positive women in Niger. “Their husbands are afraid their children will not be well taken care of or will become contaminated.”

A report by the Journal of the American Medical Association (JAMA) stated that adolescents are also at risk. Knowledge about HIV prevention among young people remains low, and misconceptions persist, especially in rural communities where sexual health education is scarce.

Poverty and the Global Connection

HIV and poverty form a vicious cycle. Illness limits productivity, weakens households and deepens food insecurity. A report that UNAIDS and the World Food Programme (WFP) did in 2022 found that for families already surviving on less than $2 a day, one untreated infection can mean lost income and school dropouts.

The link extends beyond Niger. Global efforts to end extreme poverty rely on stable, healthy populations. In the same report, the World Food Programme and UNAIDS launched a joint cash-transfer project that provides small stipends (≈ US $76 per quarter) to people living with HIV to improve treatment adherence, underscoring the inseparable link between health and development.

Solutions in Action

One organization leading change is Solthis, an international Non-Governmental Organization (NGO) partnering with Niger’s Ministry of Health to strengthen HIV prevention and care. Through its Lahiyata project launched in 2023, Solthis works in Maradi and Niamey to improve sexual and reproductive health among adolescent girls, offering education, counseling and access to HIV and STI testing. In addition, Solthis technical support program helped train health workers, upgrade laboratories and expand treatment access nationwide. According to data from UNAIDS, between 2022 and 2023, more than one million pregnant women in Niger received voluntary HIV counseling and testing, linking many to lifesaving antiretroviral therapy.

Progress and the Path Ahead

Niger’s progress is real: ART coverage has grown from 26% in 2011 to 68% in 2020, likely attributed to the increase of foreign aid between 2015 and 2020 and Niger’s adoption of UNAIDS’ “90-90-90” prevention framework, and nationwide awareness campaigns are improving testing uptake. But sustainability is fragile. Most funding comes from international donors, and local programs risk collapsing if aid declines, per UNAIDS. To secure its future, Niger must expand ART coverage for HIV/AIDS in Niger, target key populations, and confront stigma through education and inclusion.

– Matt Irwin

Matt is based in Brooklyn, NY, USA and focuses on Global Health for The Borgen Project.

Photo: Wikimedia Commons

, ,

mRNA: A Key Breakthrough in Developing an HIV vaccine

mRNA: A Key Breakthrough in Developing an HIV vaccine The human immunodeficiency virus, more commonly known as HIV, is one of the most widespread diseases in the world. According to the World Health Organization (WHO), HIV affects 40.8 million people around the world as of the end of 2024, and in 2024, HIV killed a total of 630,000 people. This article looks at the populations most at risk for HIV, as well as a new study that could lead to an HIV vaccine.

Populations At Risk

While anyone can contract HIV, certain groups face disproportionately higher risks due to social, economic and structural factors. Globally, key populations include gay and bisexual men, sex workers, people who inject drugs and transgender individuals—groups that often encounter stigma, limited access to health care and higher exposure to risk. The southern area of Africa has the highest rates of HIV, with the countries of Eswatini and Lesotho having the highest rates in the world at 27% and 20.5%, respectively. These statistics help paint a better picture of the people that HIV affects the most, as well as point to the need for an HIV vaccine.

HIV Vaccine: Developmental Progress

Recently, researchers published a new study in Science Translational Medicine. According to The Foundation for AIDS Research (amfAR), the tested vaccine uses an mRNA structure similar to the COVID-19 vaccine that could provide cells with the necessary information to fight an HIV infection by creating a membrane-bound version of HIV that would be easier for cells to fight, and develop an immune response that would take effect if it ever came into contact with HIV.

After successful tests in animals, human trials started. While some of the participants developed a rash as a result of the vaccine, the results were overall effective, with many people developing the necessary antibodies to fight against HIV. Overall, the tests proved that there is at least a path forward to developing an HIV vaccine. However, actions by the U.S. government led to a loss of funding, which could stall the progress of an HIV vaccine. But the progress so far shows that an HIV vaccine is possible in the future.

Looking Ahead

HIV remains a major global health concern. The recent mRNA-based study demonstrates that an HIV vaccine is within reach, offering hope that continued research and support could one day lead to a breakthrough capable of saving millions of lives worldwide.

– Charlie Means

Charlie is based in Denver, CO, USA and focuses on Good News and Global Health for The Borgen Project.

Photo: Pixabay

, ,

Progress and Possibility Behind HIV/AIDS in Guatemala

HIV/AIDS in GuatemalaGuatemala has made significant progress in its fight against HIV/AIDS. While it may not make headlines every day, Guatemala’s advancements are persistent and deeply human. The country is steadily moving towards the UNAIDS target of 95% of people knowing their virus status, 95% of people on treatment and 95% achieving viral suppression. Tucked between mountain roads and the Caribbean coast and once overwhelmed by stigma, unequal health care infrastructure and limited access to treatment, Guatemalans now have expanded access to treatment, information and community. The trajectory of meeting these 95–95–95 targets is palpable.

At a time, those numbers felt out of reach. Today, however, the change is measurable. Approximately 33,000 Guatemalans are living with HIV, with an adult prevalence rate of just 0.2–0.3%, among the lowest in Latin America. Since 2010, AIDS-related deaths have fallen by nearly 40%, thanks to wider access to antiretroviral therapy (ART) and strong community-driven advocacy. About 78% of people with HIV are now receiving treatment, and two-thirds have achieved viral suppression, signaling significant and lasting progress in care accessibility. Yet, this progress also underscores how deeply health outcomes are tied to economic inequality. Poverty continues to limit access to testing and treatment, especially in rural areas where clinics and transportation remain scarce. The progress of HIV/AIDS in Guatemala reflects not only medical advancement but also the broader effort to close the gap between health and opportunity.

Confronting Stigma With Inclusion

Progress rarely comes without resistance, a major barrier for Guatemala’s HIV response being stigma. It lingers in small towns, classrooms and suppressed conversation. In a national survey, 57% of adults said they would not buy food from someone with HIV, and only 22% of youth accurately understood prevention methods. Lurking behind those numbers is a deep cultural fear. Still, the response has been just as powerful. 

Local organizations and youth-led campaigns now promote inclusive education, normalize testing and support open conversations around sexual health. Across Guatemala, people are bringing HIV education to light, and what once kept people in the shadows out of fear of judgment is slowly being replaced with visibility and open dialogue.

Although ART is free through Guatemala’s public health system, discrimination once kept many people from seeking it out. A study found that only 35% of those living with HIV were engaged in care, and just 16% achieved viral suppression at that time. In response, Guatemala has expanded mobile testing, integrated HIV services into community health centers and strengthened privacy protections for patients. While these changes may sound procedural, local testing means local recovery and accessibility. These reforms are especially important for low-income communities, where poverty and stigma often intersect.

Local Activism Leading the Fight Against HIV/AIDS in Guatemala

Change often begins with one voice. Guatemalan advocate Alma de León from the International Treatment Preparedness Coalition–Latin America and the Caribbean has shown how activism can drive national reform. Her coalition helped lower the price of dolutegravir, a key HIV medication, from $240 to $7 per patient, while also simplifying treatment options from more than 200 combinations to fewer than 65. These changes make treatment affordable and sustainable, and allow the fight against the stigma of HIV/AIDS in Guatemala to reach communities and families facing economic hardship who may otherwise lack access to consistent health care.

Multi-month ART refills have also redefined accessibility for rural workers who may have once spent an entire day traveling to refill their prescriptions. This approach, paired with peer-led outreach and telehealth mentoring for rural doctors, is creating practical changes to create a flexible, efficient and human health care system.

A Future Built on Collaboration

This progress is not happening in isolation. Partnerships with international groups like the U.S. Centers for Disease Control and Prevention (CDC) have strengthened infrastructure through programs like Project ECHO, which links local clinicians to specialists for real-time mentoring. Other initiatives like the multi-month prescriptions and pharmacy fast-track refills are easing that daily burden on patients.  

These strategies altogether create a true ripple effect to better training, fewer barriers and stronger communities. Efforts show that treatment is not a sole indicator of success, but proof of a shared effort over time.

Hope on the Horizon

Guatemala’s HIV response is a story of persistence and partnership. Deaths are falling, access is expanding and education and empathy are replacing stigma. Emerging outcomes are indicators of collaboration, local activism, global outreach and most importantly, communities refusing to be defined by fear. The fight against HIV/AIDS in Guatemala has deep ties to the nation’s fight against poverty. By improving access to care and breaking down economic barriers, Guatemala is showing how public health progress can also strengthen economic resilience.

Continued investment in local leadership, youth empowerment and international cooperation will ensure this fight not only meets but exceeds global goals. Guatemala is proving that ending HIV is not just possible, it’s already happening.

– Ella Bogdan

Ella is based in Denver, CO, USA and focuses on Global Health for The Borgen Project.

Photo: Unsplash

, ,

HIV in Zimbabwe

HIV in ZimbabweZimbabwe is a country located in southern Africa. It shares its borders with South Africa to the south, Zambia to the north, Mozambique to the east and Botswana to the west. Harare, the largest city and at the same time the capital, lies in the northeastern part of the land.

Zimbabwe’s population is about 17 million, with the average age of a citizen being 18. The political system is a constitutional democracy and most of its population practices Christianity. Despite its vast size, natural beauty and rich cultural heritage, HIV in Zimbabwe remains a significant public health challenge.

The Prevalence of HIV

HIV in Zimbabwe is becoming an increasingly serious problem. In 2024, about 1.3 million people were living with the virus, most of whom were adults. Notably, women made up a significantly larger share of those affected, with 740,000 cases compared to 490,000 among men.

Despite the progress made in prevention and treatment, economic instability and limited public health funding continue to threaten the country’s response to HIV. The national currency’s devaluation and rising inflation have reduced health care budgets and led to shortages of medicines in some regions.

In early 2025, cuts and freezes in international funding, including a temporary suspension of economic support, took effect. As a result, several HIV clinics closed and the ARV supply was interrupted, leaving thousands without help. Experts and health organizations have warned that such disruptions could reverse years of progress in HIV control and treatment adherence.

Key Populations

In Zimbabwe, key populations, especially female sex workers, bear a substantially higher burden of HIV than the general population. About half of female sex workers have HIV in Zimbabwe. The prevention is difficult because many in the key population don’t even know their HIV status, spreading the illness further.

Women and girls, despite progress in some areas of education, remain underrepresented in formal employment and are more exposed to poverty. Many women rely on the informal sector for income, such as street vending and odd jobs, which often yield irregular earnings, making it difficult to afford health care, clinic transport or consistent treatment. In some cases, the urgency to provide for dependents leads to “survival sex” or informal transactional relationships.

Fighting HIV

Zimbabwe has made significant progress in combating HIV, with strong backing from the Global Fund, PEPFAR, UNDP and local civil society groups. According to recent reports, about 93% of people living with HIV in Zimbabwe know their status, 98% of those diagnosed are receiving antiretroviral therapy (ART) and 95% of those on ART have achieved viral suppression. However, sustaining these gains remains a challenge.

Despite substantial external support, Zimbabwe faces a funding gap of about $133 million in 2024 to fully meet the resource needs outlined in its strategic HIV plan. Recent freezes and reductions in donor funding, including from USAID, have raised serious concerns about maintaining services, clinics, ART supply and outreach, particularly for vulnerable and marginalized groups.

With continued, focused commitment from international partners and increased domestic investment, Zimbabwe aims to maintain and strengthen HIV prevention and treatment services. Key elements include expanding local funding sources, ensuring that services for key populations remain prioritized, sustaining supply chains for ART and scaling up testing, prevention and care innovations.

– Julia Skowrońska

Julia is based in Wrocław, Poland and focuses on Global Health for The Borgen Project.

Photo: Flickr

, ,

HIV in the Central African Republic

HIV in the Central African RepublicThe Central African Republic (CAR), located in the heart of the continent, has long faced a severe HIV epidemic. While HIV has largely dwindled in threat in the West, it remains the primary cause of mortality in the CAR. In 2019, there were 4,800 deaths and 110,000 people overall living with the disease in the nation.

This epidemic has been declared a national crisis, one intensified by the lasting and prevalent stigma shadowing HIV. This fatally impacts treatment access for people living with HIV (PLHIV) in the Central African Republic. To understand and combat this situation, initiatives in the CAR piloted by Médecins Sans Frontières (MSF) and UNICEF focus on eradicating stigma-based prejudices through community-based aid. Their programs validate the significant impact of providing psychological support to PLHIV, especially in a situation that may feel hopeless.

HIV-Related Stigma

The 2018 PLHIV Stigma Index found that 87% of PLHIV experienced discrimination that affected their daily lives. The health care sector in the CAR is severely underfunded, resulting in insufficient (or sometimes zero) government-led ethics training being delivered to workers.

As a result, these professionals develop inaccurate beliefs about transmission causes and harbor fear-based prejudices against PLHIV. Hence, incidents such as humiliating comments, disclosure of HIV status and alienation from health care professionals affect PLHIV, with 12% avoiding health centers because of their status.

PLHIV in the CAR not only fear discriminatory professional care, but also fear being “found out” by their peers — an exposure that can lead to consequences such as social marginalization, family rejection or even violence from intimate partners. This double barrier creates a deep-seated fear, resulting in fatal disengagement from care, a challenge foreign aid organizations are working to address.

Antiretroviral Treatment

Campaigns across the CAR focus on utilizing community support groups to improve adherence to antiretroviral medicine (ARV) treatment plans. This medication can reduce levels of HIV to an undetectable level and protect the immune system. Thus, without access to it, PLHIV may experience numerous fatal complications and a risk to their quality of life.

However, MSF reported that, in 2016, only 18% of PLHIV in the CAR were actively undergoing ARV treatment provided by the CAR government. It found that by the time the majority of patients begin treatment, their immune systems are too badly compromised and they are already suffering from advanced and unmanageable AIDS. Chillingly, this is the case for two-thirds of PLHIV in the CAR.

Community Groups

The E Bata Guigui (Let Us Protect Life) group, initiated in 2018 by UNICEF in the CAR’s capital city, Bangui, promotes treatment through offering empathy and reassurance for PLHIV. The campaign consists of 2,000 young people offering peer solidarity, encouragement for testing and accompaniment through treatment appointments and journeys.

Results show that more young people aged 0-14 with HIV in the CAR have access to treatment, even after being deterred by their local clinics. Evidently, treating PLHIV with humanity can often be life-saving.

In 2019, MSF launched its Community Groups initiative across West Africa. The program allows one member to collect drug refills on behalf of the group, improving adherence and access to long-term treatment. Its stigma-sensitive approach — centered on self-management and peer support — has led to an increase in viral suppression and patient follow-up rates. Within a year of implementation, more than 1,800 patients had begun HIV treatment and 558 new cases were diagnosed.

Positive Changes

The milestones achieved by Community Group programs surrounding early diagnosis, medication uptake and treatment adherence show valuable strides toward a brighter, healthier future for PLHIV in the CAR. While challenges remain, the progress made in tackling widespread discrimination, through greater acceptance and enhanced psychological support, has already bettered both physical and mental health outcomes, delivering hope to those who once felt there was none.

– Emily Wooster

Emily is based in Birmingham, UK and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

HIV/AIDS in Guatemala

hiv/Aids in guatemalaHIV/AIDS has been one of the most taboo diseases to date, with many having negative attitudes and beliefs about people who have it. Harmful stereotypes about HIV/AIDS have prevented those who need help from getting the proper treatment they deserve. In Guatemala, this is no different. This article will explain the facts about HIV/AIDS in Guatemala as well as what it’s like to live with the disease.

HIV/AIDS Has Steadily Been Rising Since 1990

HIV/AIDS has affected the lives of more than 30,000 registered citizens in Guatemala since 1990. In 1990, the case toll was 8,000. However, in 2024, an estimated 33,000 citizens contracted HIV/AIDS. Of this 33,000, around 21,000 men and 12,000 women are living with HIV/AIDS. While homosexuality is legal, laws to protect LGBTQ+ citizens are not comprehensive. This has led to discrimination among LGBTQ+ citizens, which further stigmatizes diseases such as HIV/AIDS. According to Lokal Travel, “Despite legal acceptance, the LGBT community often faces discrimination and, in some cases, violence.” Because of this, having a disease such as HIV/AIDS can not only come with discrimination, but

also violence that could be life-threatening.

Highest Rates of HIV/AIDS

Queer men and transgender women are the most at-risk individuals to contract HIV/AIDS. This is because comprehensive sex education isn’t taught, leading to a lack of protection being used during sex. UNAIDS reports that “ the HIV prevalence rate is 22.2% among the transgender population, compared to 0.2% for the general population.” It also reports that even though rates among the general population for HIV/AIDS are beginning to decrease, transgender women are still contracting the disease at the same rate as before. This highlights the lack of protection transgender women face within healthcare in Guatemala.

Stigma Surrounding HIV/AIDS Testing Is High

Getting tested for HIV/AIDS is crucial to preventing the disease from spreading. If caught in the early stages, HIV can be managed through medication, making the person undetectable to others. However, without testing, the disease will continue to cause havoc within the person’s body. UNAIDS reports that around 47%-73% of transgender women avoid being tested due to the stigma surrounding HIV/AIDS in Guatemala. This stigma can further result in mental health issues such as anxiety and depression, forming within citizens living with HIV/AIDS in Guatemala.

HIV Clinics

According to AIDS Health, AHF has built clinics in Guatemala to help promote citizens being tested for HIV/AIDS. The clinic can offer ARV treatments to those living with HIV/AIDS in Guatemala. This helps those living with HIV/AIDS have access to life-saving treatment without having to pay a fortune. Because of this, over the past years, the clinics have performed more than 600,00 rapid tests across various settings, a monumental achievement that has been able to reduce some of the stigma surrounding HIV/AIDS and allow citizens to feel comfortable being tested and treated.

HIV/AIDS Can Affect Anyone

Miscommunication about HIV/AIDS has been raging since the 1980s. Many people hold false assumptions that only queer men can contract HIV/AIDS. However, they’re excluding a large chunk of the vulnerable population.

According to The MANGUA Project, “HIV prevalence among other vulnerable groups is 18% in people with tuberculosis (TB), 13% in prison populations, and 3.3% among youth at social risk,” showing how people who are in vulnerable positions are equally at risk for HIV/AIDS. This is important to emphasize so that HIV/AIDS can become destigmatized. It can show that anyone can contract HIV/AIDS if they are in an unsafe situation.

– Alexis Thomas

Alexis is based in Author’s City and State: Raleigh,NC/Wake, USA and focuses on Global Health for The Borgen Project.

Photo: Flickr

, ,

HIV/AIDS in Slovenia: A Case of Universal Treatment

HIVAIDS in SloveniaSlovenia is a success story in many aspects of development, and their success in keeping HIV prevalence low is no different. Universal access to treatment, a focused prevention strategy and gradually decreasing stigma surrounding HIV/AIDS have coalesced to form a unified approach.

HIV/AIDS in Slovenia has failed to escalate into a dominant issue, largely thanks to significant progress in addressing broader inequality, with Slovenia having one of the lowest income inequalities in the European Union. With this foundation, Slovenia is a great illustration of how reducing social and economic inequality has helped to mitigate HIV/AIDS rates.

A Foundation of Effective Treatment

As of 2022, the HIV/AIDS prevalence rate of the Slovenian population between 15-49 was 0.1%, with the most affected group being men who have sex with men (MSM). While there was a rapid increase in MSM cases by 2008, prevalence has remained low due to strong, universal access to treatment which encompasses Slovenian citizens and migrants with employment status.

Strong public health frameworks across the country ensures access to treatment is viable for most of the population with citizens, migrant workers, asylum seekers and refugees receiving comprehensive medical services, including HIV care.

The Infectious Disease Clinic at the medical faculty for University of Ljubljana leads the way for active antiretroviral therapy with voluntary clinics and testing centers available across the country to ensure treatment can be effective through early diagnosis.

Prioritizing Prevention Key to Success

Alongside universal access to treatment, continuous focus on prevention has enabled transmission rates to be continuously low, promoting safe behavior regarding sexual activity. The Institute of Public Health in Slovenia has continued to promote educational messages annually to align with World AIDS Day, encouraging awareness through mainstream public health messages to destigmatize the issue.

Initiatives in primary and secondary schools have also contributed to an effective prevention strategy, distributing HIV education materials and encouraging condom use more broadly. A significant increase in condom use in Slovenia demonstrated that, at least in heterosexual contexts, HIV related promotion surrounding condom use was effective. Despite the culmination of these disparate efforts succeeding in maintaining low HIV prevalence, deep-rooted stigmas remain that threaten to entrench social inequalities.

The Power of Stigma

There is an evident stigma attached to HIV/AIDS in Slovenia, which relates to broader conservatism in the country. While that has gradually receded, it is still prominent. A significant number of people in Slovenia conceal their HIV-positive status out of fear of discrimination. Lingering stigma and discrimination are one of the primary barriers in completely eradicating HIV infections, including discrimination within public health care settings.

Slovenia holds solutions to these issues though and one includes the work of non-governmental organizations (NGOs). Legebitra is an NGO based in Slovenia’s capital city of Ljubljana. It has spearheaded programs surrounding HIV prevention and treatment since 2009, opening multiple HIV and STI testing clinics across Ljubljana and other major cities in Slovenia.

It is not only testing where Legebitra has made an impact, but its educational programs are vital at addressing stigmatized issues. Its “HIV+” program has provided counselling to people living with HIV, as well as increasing awareness of taboo subjects which endanger marginalized groups. Crucially, Legebitra offers its testing services and educational programs for free, ensuring that people living in poverty do not suffer the intersectional consequences of low socio-economic status and discrimination.

A Nation Moving Forward

Grassroots, community-based educational messaging and maintaining accessible treatment for deprived groups has softened stigma surrounding HIV. There is a correlation between poverty rates and HIV prevalence, stemming from socio-economic inequalities affecting vulnerable populations such as migrants and the unemployed. Slovenia’s health care policy of providing comprehensive HIV care to migrant workers and asylum seekers has enabled marginalized communities to have access to sufficient care, demonstrating that Slovenia’s progress towards social progression has helped to mitigate HIV infections.

Focusing on cases involving MSM has proved a prudent strategy, with HIV prevalence remaining low despite the initial increase in cases from 2006. Efforts made to psychologically support vulnerable groups at risk from HIV and provide free treatment has supplemented Slovenia’s broader trend of mitigating inequalities and ensuring that while HIV/AIDS in Slovenia is not a universal problem, everyone has the universal right to access help.

– Oscar McClintock

Oscar is based in Cambridge, UK and focuses on Global Health for The Borgen Project.

Photo: Unsplash